Skip to content
IP + Technology Law
Home  »  News & Insights  »  News

Partner Brent Babcock Discusses New CRISPR IP Alliance

December 19, 2016  | Brenton R. Babcock

Partner Brent Babcock, Chair of the firm’s USPTO Trials & Post-Grant Proceedings group, was quoted in “Some Consensus in the CRISPR Patent Case,” an article published in MedCity News. The article discuses four companies founded in the CRISPR space that announced last Friday, December 16, that they had formed an IP alliance.

Read the article here

 

Related Links

Industries

News & Insights

News
Feb 2026
In Law360 Interview, Jarom Kesler Offers Insights on How Law Firms Are Adopting AI Tools
In the Law360 article “IP Firms Are Navigating AI Era With Range Of Guardrails,” Knobbe Martens partner Jarom Kesler discussed the firm’s approach to the adoption and integration of generative...
Blog - Trademark & Brand Protection
Feb 2026
THC You Later – An End to the THC Supplement Industry?
Tucked away in the text of the law that ended the 2025 federal shutdown is a provision amending a handful of paragraphs from the 2018 farm bill. Although seemingly minor,...
Blog - Trademark & Brand Protection
Feb 2026
No Joy in Mudville: Federal Circuit Affirms Aaron Judge and MLBBPA’s Priority in Marks All Rise and Here Comes the Judge Based on Extensive Evidence of Licensed Use
Today, Aaron Judge (“Judge”) is a household name for sports fans across the United States. However, in 2017, Judge was just entering the Major League Baseball scene and carving out...